Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06583564

The Prognosis Effect of Indocyanine Green (ICG) Fluorescence Guided Surgery on Disease-free Survival (DFS) of Stage III Colorectal Cancer

A Single Center Randomized Controlled Study of the Prognosis After Indocyanine Green Fluorescence-guided Radical Surgery in Colorectal Cancer Patients of Stage III

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
192 (estimated)
Sponsor
Shanghai Tong Ren Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have evaluated the outcomes of this imaging technology, especially the prognosis following of colorectal cancer resection. The present study assessed the prognosis of stage III colorectal cancer patients following ICG fluorescence-guided surgery as compared to conventional surgery without the use of ICG Fluorescence imaging

Conditions

Interventions

TypeNameDescription
PROCEDUREICG lymphangiography procedureAll patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose using ICG lymphangiography procedure

Timeline

Start date
2024-09-27
Primary completion
2025-03-31
Completion
2025-03-31
First posted
2024-09-04
Last updated
2024-09-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06583564. Inclusion in this directory is not an endorsement.